Skip to main content
Clinical Trials/CTRI/2013/12/004240
CTRI/2013/12/004240
Recruiting
Phase 4

A STUDY TO EVALUATE THE EFFECTIVENESS AND SAFETY OF ACYCLOVIR IN PITYRIASIS ROSEA: AN INVESTIGATOR-BLIND RANDOMISED CLINICAL TRIAL - ESAPR

Institutional Medical College Kolkata0 sites24 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- Patients suffering from Pityriasis rosea
Sponsor
Institutional Medical College Kolkata
Enrollment
24
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Institutional Medical College Kolkata

Eligibility Criteria

Inclusion Criteria

  • a.All patients presenting with pityriasis rosea.
  • b.Patients giving informed written consent

Exclusion Criteria

  • a.Patients not willing to participate in the study
  • b.Pregnant or breast feeding women
  • c.Any history of sensitivity to acyclovir or erythromycin or cetirizine
  • d.Renal or hepatic impairment
  • e.Suspicion of having fungal infection, psoriasis, or eczema.

Outcomes

Primary Outcomes

Not specified

Similar Trials